1-1 of 1
Omer Koc, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma.

Kieron Dunleavy, M.D., John Janik, M.D., Juan Gea-Banacloche, M.D., Margaret Shovlin, B.S.N., Therese White, M.S.N., Neta Goldschmidt, M.D., Nicole Grant, M.P.H., Omer Koc, M.D., Stefania Pittaluga, M.D., Elaine Jaffe, M.D., Louis Staudt, M.D., Ph.D., Wyndham H. Wilson, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1385.
https://doi.org/10.1182/blood.V104.11.1385.1385
Published: 2004